Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the international extranodal lymphoma study group
Identifieur interne : 00B093 ( Main/Exploration ); précédent : 00B092; suivant : 00B094Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the international extranodal lymphoma study group
Auteurs : E. Zucca [Australie, Canada, France, Italie, Pérou, Roumanie, Espagne, Suisse, États-Unis, Royaume-Uni] ; A. Conconi ; T. I. Mughal ; A. H. Sarris ; J. F. Seymour ; U. Vitolo ; R. Klasa ; M. Ozsahin ; G. M. Mead ; M. A. Gianni ; S. Cortelazzo ; A. J. M. Ferreri ; A. Ambrosetti ; M. Martelli ; C. Thieblemont ; H. Gomez Moreno ; G. Pinotti ; G. Martinelli ; R. Mozzana ; S. Grisanti ; M. Provencio ; M. Balzarotti ; F. Laveder ; G. Oltean ; V. Called ; P. Roy ; F. Cavalli ; M. K. GospodarowiczSource :
- Journal of clinical oncology [ 0732-183X ] ; 2003.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
Abstract
Purpose: To determine clinical features and patterns of outcome of primary testicular diffuse large B-cell lymphomas (DLCL). Patients and Methods: A retrospective international survey of 373 patients with primary testicular DLCL. Results: Most patients presented with localized disease (stage I to II), and the median age at diagnosis was 66 years (range, 19 to 91 years). Anthracycline-based chemotherapy was administered to 255 patients (68%), and prophylactic intrathecal chemotherapy was given to 68 patients (18%); 133 patients (36%) received prophylactic scrotal radiotherapy. Median overall survival was 4.8 years, and median progression-free survival was 4 years. The survival curves showed no clear evidence of a substantial proportion of cured patients. A favorable international prognostic index score (IPI), no B-symptoms, the use of anthracyclines, and prophylactic scrotal radiotherapy were significantly associated with longer survival at multivariate analysis. However, even for patients with stage I disease and good-risk IPI, the outcome seems worse than what was reported for DLCL at other sites. At a median follow-up of 7.6 years, 195 patients (52%) had relapsed. Extranodal recurrence was reported in 140 cases. Relapses in CNS were detected in 56 patients (15%) up to 10 years after presentation. A continuous risk of recurrence in the contralateral testis was seen in patients not receiving scrotal radiotherapy. Conclusion: Testicular DLCL is characterized by a particularly high risk of extranodal relapse even in cases with localized disease at diagnosis. Anthracycline-based chemotherapy, CNS prophylaxis, and contralateral testicular irradiation seem to improve the outcome. Their efficacy is under evaluation in a prospective clinical trial.
Affiliations:
- Australie, Canada, Espagne, France, Italie, Pérou, Roumanie, Royaume-Uni, Suisse, États-Unis
- Angleterre, Auvergne-Rhône-Alpes, Canton de Vaud, Communauté de Madrid, Grand Manchester, Latium, Piémont, Rhône-Alpes
- Lausanne, Lyon, Madrid, Manchester, Rome, Turin
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 005447
- to stream PascalFrancis, to step Curation: 000C79
- to stream PascalFrancis, to step Checkpoint: 004E65
- to stream Main, to step Merge: 00BE50
- to stream Main, to step Curation: 00B093
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the international extranodal lymphoma study group</title><author><name sortKey="Zucca, E" sort="Zucca, E" uniqKey="Zucca E" first="E." last="Zucca">E. Zucca</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Haemalology/Medical Oncology, Peter MacCallum Cancer Institute</s1><s2>East Melbourne</s2><s3>AUS</s3></inist:fA14><country>Australie</country><wicri:noRegion>East Melbourne</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Radiation Oncology, Princess Margaret Hospital</s1><s2>Toronto</s2><s3>CAN</s3></inist:fA14><country>Canada</country><wicri:noRegion>Toronto</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Division of Medical Oncology, British Columbia Cancer Agency</s1><s2>Vancouver</s2><s3>CAN</s3></inist:fA14><country>Canada</country><wicri:noRegion>Vancouver</wicri:noRegion></affiliation><affiliation wicri:level="3"><inist:fA14 i1="04"><s1>Service de Hématologie and Service de Biostatistique, Centre Hospitalier Lyon Sud</s1><s2>Lyon</s2><s3>FRA</s3></inist:fA14><country>France</country><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation><affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Divisione di Oncologia Medica, Ospedale S. Martino</s1><s2>Belluno</s2><s3>ITA</s3></inist:fA14><country>Italie</country><wicri:noRegion>Belluno</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Divisione di Ematologia, Ospededali Riuniti di Bergamo</s1><s2>Bergamo</s2><s3>ITA</s3></inist:fA14><country>Italie</country><wicri:noRegion>Bergamo</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Divisione di Medicina I, Azienda Ospedaliera S. Antonio Abate</s1><s2>Gallarate</s2><s3>ITA</s3></inist:fA14><country>Italie</country><wicri:noRegion>Gallarate</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Divisione di Oncologia Medica, Istituto Nazionale per lo Studio e la Cura del Tumori, Servizio di Radiochemioterapia, Ospe ale San Raffaele, Divisione di Ematoncologia Clinica, Istituto Europeo di Oncologia</s1><s2>Milano</s2><s3>ITA</s3></inist:fA14><country>Italie</country><wicri:noRegion>Milano</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Dipartimento di Oncologia Medica ed Ematologia, Istituto Clinico Humanitas</s1><s2>Milano</s2><s3>ITA</s3></inist:fA14><country>Italie</country><wicri:noRegion>Milano</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="10"><s1>Divisone Ematologia, Azienda Ospedaliera "Bianchi-Melacrino-Morelli"</s1><s2>Reggio Calabria</s2><s3>ITA</s3></inist:fA14><country>Italie</country><wicri:noRegion>Reggio Calabria</wicri:noRegion></affiliation><affiliation wicri:level="3"><inist:fA14 i1="11"><s1>Dipartimento di Biotecnologie Cellulari ed Ematologia, Università degli Studi "La Sapienza"</s1><s2>Roma</s2><s3>ITA</s3></inist:fA14><country>Italie</country><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation><affiliation wicri:level="3"><inist:fA14 i1="12"><s1>Divisione di Ematologia, Azienda Ospedaliera S. Giovanni Battista</s1><s2>Torino</s2><s3>ITA</s3></inist:fA14><country>Italie</country><placeName><settlement type="city">Turin</settlement><region type="région" nuts="2">Piémont</region></placeName></affiliation><affiliation wicri:level="1"><inist:fA14 i1="13"><s1>Servizio di Oncologia Medica, Ospedale di Circolo Fondazione Macchi</s1><s2>Verase</s2><s3>ITA</s3></inist:fA14><country>Italie</country><wicri:noRegion>Verase</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="14"><s1>Divisione di Ematologia, Policlinico G.B. Rossi</s1><s2>Verona</s2><s3>ITA</s3></inist:fA14><country>Italie</country><wicri:noRegion>Verona</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="15"><s1>Instituto de Enfermedades Neoplasticas</s1><s2>Lima</s2><s3>PER</s3></inist:fA14><country>Pérou</country><wicri:noRegion>Instituto de Enfermedades Neoplasticas</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="16"><s1>Clin Med 1, Spit Clin Jud</s1><s2>Tirgu-Mures</s2><s3>ROM</s3></inist:fA14><country wicri:auto="ROM">Roumanie</country><wicri:noRegion>Tirgu-Mures</wicri:noRegion></affiliation><affiliation wicri:level="3"><inist:fA14 i1="17"><s1>Servicio de Oncologia Medica, Clinica Puerta de Hierio</s1><s2>Madrid</s2><s3>ESP</s3></inist:fA14><country>Espagne</country><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation><affiliation wicri:level="1"><inist:fA14 i1="18"><s1>Divisione di Oncologia Medica, Instituto Oncologico della Svizzera Italiana</s1><s2>Bellinzona</s2><s3>CHE</s3></inist:fA14><country>Suisse</country><wicri:noRegion>Bellinzona</wicri:noRegion></affiliation><affiliation wicri:level="3"><inist:fA14 i1="19"><s1>Rare Cancer Network, Service de Radio-Oncologie, Centre Hospitalier Universitaire Vaudois</s1><s2>Lausanne</s2><s3>CHE</s3></inist:fA14><country>Suisse</country><placeName><settlement type="city">Lausanne</settlement><region nuts="3" type="region">Canton de Vaud</region></placeName></affiliation><affiliation wicri:level="1"><inist:fA14 i1="20"><s1>Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center</s1><s2>Houston, TX</s2><s3>USA</s3></inist:fA14><country>États-Unis</country><wicri:noRegion>Houston, TX</wicri:noRegion></affiliation><affiliation wicri:level="3"><inist:fA14 i1="21"><s1>Department of Haematology/Meical Oncology, Christie Hospital NHS Trust</s1><s2>Manchester</s2><s3>USA</s3></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Manchester</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Manchester</region></placeName></affiliation><affiliation wicri:level="1"><inist:fA14 i1="22"><s1>Cancer Research Campaign, Wessex Medical Oncology Unit, Southampton General Hospital</s1><s2>Southampton</s2><s3>GBR</s3></inist:fA14><country>Royaume-Uni</country><wicri:noRegion>Southampton</wicri:noRegion></affiliation></author><author><name sortKey="Conconi, A" sort="Conconi, A" uniqKey="Conconi A" first="A." last="Conconi">A. Conconi</name></author><author><name sortKey="Mughal, T I" sort="Mughal, T I" uniqKey="Mughal T" first="T. I." last="Mughal">T. I. Mughal</name></author><author><name sortKey="Sarris, A H" sort="Sarris, A H" uniqKey="Sarris A" first="A. H." last="Sarris">A. H. Sarris</name></author><author><name sortKey="Seymour, J F" sort="Seymour, J F" uniqKey="Seymour J" first="J. F." last="Seymour">J. F. Seymour</name></author><author><name sortKey="Vitolo, U" sort="Vitolo, U" uniqKey="Vitolo U" first="U." last="Vitolo">U. Vitolo</name></author><author><name sortKey="Klasa, R" sort="Klasa, R" uniqKey="Klasa R" first="R." last="Klasa">R. Klasa</name></author><author><name sortKey="Ozsahin, M" sort="Ozsahin, M" uniqKey="Ozsahin M" first="M." last="Ozsahin">M. Ozsahin</name></author><author><name sortKey="Mead, G M" sort="Mead, G M" uniqKey="Mead G" first="G. M." last="Mead">G. M. Mead</name></author><author><name sortKey="Gianni, M A" sort="Gianni, M A" uniqKey="Gianni M" first="M. A." last="Gianni">M. A. Gianni</name></author><author><name sortKey="Cortelazzo, S" sort="Cortelazzo, S" uniqKey="Cortelazzo S" first="S." last="Cortelazzo">S. Cortelazzo</name></author><author><name sortKey="Ferreri, A J M" sort="Ferreri, A J M" uniqKey="Ferreri A" first="A. J. M." last="Ferreri">A. J. M. Ferreri</name></author><author><name sortKey="Ambrosetti, A" sort="Ambrosetti, A" uniqKey="Ambrosetti A" first="A." last="Ambrosetti">A. Ambrosetti</name></author><author><name sortKey="Martelli, M" sort="Martelli, M" uniqKey="Martelli M" first="M." last="Martelli">M. Martelli</name></author><author><name sortKey="Thieblemont, C" sort="Thieblemont, C" uniqKey="Thieblemont C" first="C." last="Thieblemont">C. Thieblemont</name></author><author><name sortKey="Gomez Moreno, H" sort="Gomez Moreno, H" uniqKey="Gomez Moreno H" first="H." last="Gomez Moreno">H. Gomez Moreno</name></author><author><name sortKey="Pinotti, G" sort="Pinotti, G" uniqKey="Pinotti G" first="G." last="Pinotti">G. Pinotti</name></author><author><name sortKey="Martinelli, G" sort="Martinelli, G" uniqKey="Martinelli G" first="G." last="Martinelli">G. Martinelli</name></author><author><name sortKey="Mozzana, R" sort="Mozzana, R" uniqKey="Mozzana R" first="R." last="Mozzana">R. Mozzana</name></author><author><name sortKey="Grisanti, S" sort="Grisanti, S" uniqKey="Grisanti S" first="S." last="Grisanti">S. Grisanti</name></author><author><name sortKey="Provencio, M" sort="Provencio, M" uniqKey="Provencio M" first="M." last="Provencio">M. Provencio</name></author><author><name sortKey="Balzarotti, M" sort="Balzarotti, M" uniqKey="Balzarotti M" first="M." last="Balzarotti">M. Balzarotti</name></author><author><name sortKey="Laveder, F" sort="Laveder, F" uniqKey="Laveder F" first="F." last="Laveder">F. Laveder</name></author><author><name sortKey="Oltean, G" sort="Oltean, G" uniqKey="Oltean G" first="G." last="Oltean">G. Oltean</name></author><author><name sortKey="Called, V" sort="Called, V" uniqKey="Called V" first="V." last="Called">V. Called</name></author><author><name sortKey="Roy, P" sort="Roy, P" uniqKey="Roy P" first="P." last="Roy">P. Roy</name></author><author><name sortKey="Cavalli, F" sort="Cavalli, F" uniqKey="Cavalli F" first="F." last="Cavalli">F. Cavalli</name></author><author><name sortKey="Gospodarowicz, M K" sort="Gospodarowicz, M K" uniqKey="Gospodarowicz M" first="M. K." last="Gospodarowicz">M. K. Gospodarowicz</name></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">03-0109536</idno><date when="2003">2003</date><idno type="stanalyst">PASCAL 03-0109536 INIST</idno><idno type="RBID">Pascal:03-0109536</idno><idno type="wicri:Area/PascalFrancis/Corpus">005447</idno><idno type="wicri:Area/PascalFrancis/Curation">000C79</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">004E65</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">004E65</idno><idno type="wicri:doubleKey">0732-183X:2003:Zucca E:patterns:of:outcome</idno><idno type="wicri:Area/Main/Merge">00BE50</idno><idno type="wicri:Area/Main/Curation">00B093</idno><idno type="wicri:Area/Main/Exploration">00B093</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the international extranodal lymphoma study group</title><author><name sortKey="Zucca, E" sort="Zucca, E" uniqKey="Zucca E" first="E." last="Zucca">E. Zucca</name><affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Division of Haemalology/Medical Oncology, Peter MacCallum Cancer Institute</s1><s2>East Melbourne</s2><s3>AUS</s3></inist:fA14><country>Australie</country><wicri:noRegion>East Melbourne</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Department of Radiation Oncology, Princess Margaret Hospital</s1><s2>Toronto</s2><s3>CAN</s3></inist:fA14><country>Canada</country><wicri:noRegion>Toronto</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Division of Medical Oncology, British Columbia Cancer Agency</s1><s2>Vancouver</s2><s3>CAN</s3></inist:fA14><country>Canada</country><wicri:noRegion>Vancouver</wicri:noRegion></affiliation><affiliation wicri:level="3"><inist:fA14 i1="04"><s1>Service de Hématologie and Service de Biostatistique, Centre Hospitalier Lyon Sud</s1><s2>Lyon</s2><s3>FRA</s3></inist:fA14><country>France</country><placeName><region type="region">Auvergne-Rhône-Alpes</region><region type="old region">Rhône-Alpes</region><settlement type="city">Lyon</settlement></placeName></affiliation><affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Divisione di Oncologia Medica, Ospedale S. Martino</s1><s2>Belluno</s2><s3>ITA</s3></inist:fA14><country>Italie</country><wicri:noRegion>Belluno</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Divisione di Ematologia, Ospededali Riuniti di Bergamo</s1><s2>Bergamo</s2><s3>ITA</s3></inist:fA14><country>Italie</country><wicri:noRegion>Bergamo</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Divisione di Medicina I, Azienda Ospedaliera S. Antonio Abate</s1><s2>Gallarate</s2><s3>ITA</s3></inist:fA14><country>Italie</country><wicri:noRegion>Gallarate</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Divisione di Oncologia Medica, Istituto Nazionale per lo Studio e la Cura del Tumori, Servizio di Radiochemioterapia, Ospe ale San Raffaele, Divisione di Ematoncologia Clinica, Istituto Europeo di Oncologia</s1><s2>Milano</s2><s3>ITA</s3></inist:fA14><country>Italie</country><wicri:noRegion>Milano</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Dipartimento di Oncologia Medica ed Ematologia, Istituto Clinico Humanitas</s1><s2>Milano</s2><s3>ITA</s3></inist:fA14><country>Italie</country><wicri:noRegion>Milano</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="10"><s1>Divisone Ematologia, Azienda Ospedaliera "Bianchi-Melacrino-Morelli"</s1><s2>Reggio Calabria</s2><s3>ITA</s3></inist:fA14><country>Italie</country><wicri:noRegion>Reggio Calabria</wicri:noRegion></affiliation><affiliation wicri:level="3"><inist:fA14 i1="11"><s1>Dipartimento di Biotecnologie Cellulari ed Ematologia, Università degli Studi "La Sapienza"</s1><s2>Roma</s2><s3>ITA</s3></inist:fA14><country>Italie</country><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation><affiliation wicri:level="3"><inist:fA14 i1="12"><s1>Divisione di Ematologia, Azienda Ospedaliera S. Giovanni Battista</s1><s2>Torino</s2><s3>ITA</s3></inist:fA14><country>Italie</country><placeName><settlement type="city">Turin</settlement><region type="région" nuts="2">Piémont</region></placeName></affiliation><affiliation wicri:level="1"><inist:fA14 i1="13"><s1>Servizio di Oncologia Medica, Ospedale di Circolo Fondazione Macchi</s1><s2>Verase</s2><s3>ITA</s3></inist:fA14><country>Italie</country><wicri:noRegion>Verase</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="14"><s1>Divisione di Ematologia, Policlinico G.B. Rossi</s1><s2>Verona</s2><s3>ITA</s3></inist:fA14><country>Italie</country><wicri:noRegion>Verona</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="15"><s1>Instituto de Enfermedades Neoplasticas</s1><s2>Lima</s2><s3>PER</s3></inist:fA14><country>Pérou</country><wicri:noRegion>Instituto de Enfermedades Neoplasticas</wicri:noRegion></affiliation><affiliation wicri:level="1"><inist:fA14 i1="16"><s1>Clin Med 1, Spit Clin Jud</s1><s2>Tirgu-Mures</s2><s3>ROM</s3></inist:fA14><country wicri:auto="ROM">Roumanie</country><wicri:noRegion>Tirgu-Mures</wicri:noRegion></affiliation><affiliation wicri:level="3"><inist:fA14 i1="17"><s1>Servicio de Oncologia Medica, Clinica Puerta de Hierio</s1><s2>Madrid</s2><s3>ESP</s3></inist:fA14><country>Espagne</country><placeName><settlement type="city">Madrid</settlement><region nuts="2" type="region">Communauté de Madrid</region></placeName></affiliation><affiliation wicri:level="1"><inist:fA14 i1="18"><s1>Divisione di Oncologia Medica, Instituto Oncologico della Svizzera Italiana</s1><s2>Bellinzona</s2><s3>CHE</s3></inist:fA14><country>Suisse</country><wicri:noRegion>Bellinzona</wicri:noRegion></affiliation><affiliation wicri:level="3"><inist:fA14 i1="19"><s1>Rare Cancer Network, Service de Radio-Oncologie, Centre Hospitalier Universitaire Vaudois</s1><s2>Lausanne</s2><s3>CHE</s3></inist:fA14><country>Suisse</country><placeName><settlement type="city">Lausanne</settlement><region nuts="3" type="region">Canton de Vaud</region></placeName></affiliation><affiliation wicri:level="1"><inist:fA14 i1="20"><s1>Department of Lymphoma and Myeloma, M.D. Anderson Cancer Center</s1><s2>Houston, TX</s2><s3>USA</s3></inist:fA14><country>États-Unis</country><wicri:noRegion>Houston, TX</wicri:noRegion></affiliation><affiliation wicri:level="3"><inist:fA14 i1="21"><s1>Department of Haematology/Meical Oncology, Christie Hospital NHS Trust</s1><s2>Manchester</s2><s3>USA</s3></inist:fA14><country>États-Unis</country><placeName><settlement type="city">Manchester</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Manchester</region></placeName></affiliation><affiliation wicri:level="1"><inist:fA14 i1="22"><s1>Cancer Research Campaign, Wessex Medical Oncology Unit, Southampton General Hospital</s1><s2>Southampton</s2><s3>GBR</s3></inist:fA14><country>Royaume-Uni</country><wicri:noRegion>Southampton</wicri:noRegion></affiliation></author><author><name sortKey="Conconi, A" sort="Conconi, A" uniqKey="Conconi A" first="A." last="Conconi">A. Conconi</name></author><author><name sortKey="Mughal, T I" sort="Mughal, T I" uniqKey="Mughal T" first="T. I." last="Mughal">T. I. Mughal</name></author><author><name sortKey="Sarris, A H" sort="Sarris, A H" uniqKey="Sarris A" first="A. H." last="Sarris">A. H. Sarris</name></author><author><name sortKey="Seymour, J F" sort="Seymour, J F" uniqKey="Seymour J" first="J. F." last="Seymour">J. F. Seymour</name></author><author><name sortKey="Vitolo, U" sort="Vitolo, U" uniqKey="Vitolo U" first="U." last="Vitolo">U. Vitolo</name></author><author><name sortKey="Klasa, R" sort="Klasa, R" uniqKey="Klasa R" first="R." last="Klasa">R. Klasa</name></author><author><name sortKey="Ozsahin, M" sort="Ozsahin, M" uniqKey="Ozsahin M" first="M." last="Ozsahin">M. Ozsahin</name></author><author><name sortKey="Mead, G M" sort="Mead, G M" uniqKey="Mead G" first="G. M." last="Mead">G. M. Mead</name></author><author><name sortKey="Gianni, M A" sort="Gianni, M A" uniqKey="Gianni M" first="M. A." last="Gianni">M. A. Gianni</name></author><author><name sortKey="Cortelazzo, S" sort="Cortelazzo, S" uniqKey="Cortelazzo S" first="S." last="Cortelazzo">S. Cortelazzo</name></author><author><name sortKey="Ferreri, A J M" sort="Ferreri, A J M" uniqKey="Ferreri A" first="A. J. M." last="Ferreri">A. J. M. Ferreri</name></author><author><name sortKey="Ambrosetti, A" sort="Ambrosetti, A" uniqKey="Ambrosetti A" first="A." last="Ambrosetti">A. Ambrosetti</name></author><author><name sortKey="Martelli, M" sort="Martelli, M" uniqKey="Martelli M" first="M." last="Martelli">M. Martelli</name></author><author><name sortKey="Thieblemont, C" sort="Thieblemont, C" uniqKey="Thieblemont C" first="C." last="Thieblemont">C. Thieblemont</name></author><author><name sortKey="Gomez Moreno, H" sort="Gomez Moreno, H" uniqKey="Gomez Moreno H" first="H." last="Gomez Moreno">H. Gomez Moreno</name></author><author><name sortKey="Pinotti, G" sort="Pinotti, G" uniqKey="Pinotti G" first="G." last="Pinotti">G. Pinotti</name></author><author><name sortKey="Martinelli, G" sort="Martinelli, G" uniqKey="Martinelli G" first="G." last="Martinelli">G. Martinelli</name></author><author><name sortKey="Mozzana, R" sort="Mozzana, R" uniqKey="Mozzana R" first="R." last="Mozzana">R. Mozzana</name></author><author><name sortKey="Grisanti, S" sort="Grisanti, S" uniqKey="Grisanti S" first="S." last="Grisanti">S. Grisanti</name></author><author><name sortKey="Provencio, M" sort="Provencio, M" uniqKey="Provencio M" first="M." last="Provencio">M. Provencio</name></author><author><name sortKey="Balzarotti, M" sort="Balzarotti, M" uniqKey="Balzarotti M" first="M." last="Balzarotti">M. Balzarotti</name></author><author><name sortKey="Laveder, F" sort="Laveder, F" uniqKey="Laveder F" first="F." last="Laveder">F. Laveder</name></author><author><name sortKey="Oltean, G" sort="Oltean, G" uniqKey="Oltean G" first="G." last="Oltean">G. Oltean</name></author><author><name sortKey="Called, V" sort="Called, V" uniqKey="Called V" first="V." last="Called">V. Called</name></author><author><name sortKey="Roy, P" sort="Roy, P" uniqKey="Roy P" first="P." last="Roy">P. Roy</name></author><author><name sortKey="Cavalli, F" sort="Cavalli, F" uniqKey="Cavalli F" first="F." last="Cavalli">F. Cavalli</name></author><author><name sortKey="Gospodarowicz, M K" sort="Gospodarowicz, M K" uniqKey="Gospodarowicz M" first="M. K." last="Gospodarowicz">M. K. Gospodarowicz</name></author></analytic><series><title level="j" type="main">Journal of clinical oncology</title><title level="j" type="abbreviated">J. clin. oncol.</title><idno type="ISSN">0732-183X</idno><imprint><date when="2003">2003</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Journal of clinical oncology</title><title level="j" type="abbreviated">J. clin. oncol.</title><idno type="ISSN">0732-183X</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anthracyclins</term><term>Antineoplastic agent</term><term>B-Lymphocyte</term><term>Chemotherapy</term><term>Combined treatment</term><term>Human</term><term>Intravenous administration</term><term>Large cell lymphoma</term><term>Prognosis</term><term>Radiotherapy</term><term>Testicle</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Lymphome grande cellule</term><term>Testicule</term><term>Lymphocyte B</term><term>Anthracyclines</term><term>Anticancéreux</term><term>Chimiothérapie</term><term>Radiothérapie</term><term>Traitement associé</term><term>Voie intraveineuse</term><term>Pronostic</term><term>Homme</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Purpose: To determine clinical features and patterns of outcome of primary testicular diffuse large B-cell lymphomas (DLCL). Patients and Methods: A retrospective international survey of 373 patients with primary testicular DLCL. Results: Most patients presented with localized disease (stage I to II), and the median age at diagnosis was 66 years (range, 19 to 91 years). Anthracycline-based chemotherapy was administered to 255 patients (68%), and prophylactic intrathecal chemotherapy was given to 68 patients (18%); 133 patients (36%) received prophylactic scrotal radiotherapy. Median overall survival was 4.8 years, and median progression-free survival was 4 years. The survival curves showed no clear evidence of a substantial proportion of cured patients. A favorable international prognostic index score (IPI), no B-symptoms, the use of anthracyclines, and prophylactic scrotal radiotherapy were significantly associated with longer survival at multivariate analysis. However, even for patients with stage I disease and good-risk IPI, the outcome seems worse than what was reported for DLCL at other sites. At a median follow-up of 7.6 years, 195 patients (52%) had relapsed. Extranodal recurrence was reported in 140 cases. Relapses in CNS were detected in 56 patients (15%) up to 10 years after presentation. A continuous risk of recurrence in the contralateral testis was seen in patients not receiving scrotal radiotherapy. Conclusion: Testicular DLCL is characterized by a particularly high risk of extranodal relapse even in cases with localized disease at diagnosis. Anthracycline-based chemotherapy, CNS prophylaxis, and contralateral testicular irradiation seem to improve the outcome. Their efficacy is under evaluation in a prospective clinical trial.</div></front></TEI><affiliations><list><country><li>Australie</li><li>Canada</li><li>Espagne</li><li>France</li><li>Italie</li><li>Pérou</li><li>Roumanie</li><li>Royaume-Uni</li><li>Suisse</li><li>États-Unis</li></country><region><li>Angleterre</li><li>Auvergne-Rhône-Alpes</li><li>Canton de Vaud</li><li>Communauté de Madrid</li><li>Grand Manchester</li><li>Latium</li><li>Piémont</li><li>Rhône-Alpes</li></region><settlement><li>Lausanne</li><li>Lyon</li><li>Madrid</li><li>Manchester</li><li>Rome</li><li>Turin</li></settlement></list><tree><noCountry><name sortKey="Ambrosetti, A" sort="Ambrosetti, A" uniqKey="Ambrosetti A" first="A." last="Ambrosetti">A. Ambrosetti</name><name sortKey="Balzarotti, M" sort="Balzarotti, M" uniqKey="Balzarotti M" first="M." last="Balzarotti">M. Balzarotti</name><name sortKey="Called, V" sort="Called, V" uniqKey="Called V" first="V." last="Called">V. Called</name><name sortKey="Cavalli, F" sort="Cavalli, F" uniqKey="Cavalli F" first="F." last="Cavalli">F. Cavalli</name><name sortKey="Conconi, A" sort="Conconi, A" uniqKey="Conconi A" first="A." last="Conconi">A. Conconi</name><name sortKey="Cortelazzo, S" sort="Cortelazzo, S" uniqKey="Cortelazzo S" first="S." last="Cortelazzo">S. Cortelazzo</name><name sortKey="Ferreri, A J M" sort="Ferreri, A J M" uniqKey="Ferreri A" first="A. J. M." last="Ferreri">A. J. M. Ferreri</name><name sortKey="Gianni, M A" sort="Gianni, M A" uniqKey="Gianni M" first="M. A." last="Gianni">M. A. Gianni</name><name sortKey="Gomez Moreno, H" sort="Gomez Moreno, H" uniqKey="Gomez Moreno H" first="H." last="Gomez Moreno">H. Gomez Moreno</name><name sortKey="Gospodarowicz, M K" sort="Gospodarowicz, M K" uniqKey="Gospodarowicz M" first="M. K." last="Gospodarowicz">M. K. Gospodarowicz</name><name sortKey="Grisanti, S" sort="Grisanti, S" uniqKey="Grisanti S" first="S." last="Grisanti">S. Grisanti</name><name sortKey="Klasa, R" sort="Klasa, R" uniqKey="Klasa R" first="R." last="Klasa">R. Klasa</name><name sortKey="Laveder, F" sort="Laveder, F" uniqKey="Laveder F" first="F." last="Laveder">F. Laveder</name><name sortKey="Martelli, M" sort="Martelli, M" uniqKey="Martelli M" first="M." last="Martelli">M. Martelli</name><name sortKey="Martinelli, G" sort="Martinelli, G" uniqKey="Martinelli G" first="G." last="Martinelli">G. Martinelli</name><name sortKey="Mead, G M" sort="Mead, G M" uniqKey="Mead G" first="G. M." last="Mead">G. M. Mead</name><name sortKey="Mozzana, R" sort="Mozzana, R" uniqKey="Mozzana R" first="R." last="Mozzana">R. Mozzana</name><name sortKey="Mughal, T I" sort="Mughal, T I" uniqKey="Mughal T" first="T. I." last="Mughal">T. I. Mughal</name><name sortKey="Oltean, G" sort="Oltean, G" uniqKey="Oltean G" first="G." last="Oltean">G. Oltean</name><name sortKey="Ozsahin, M" sort="Ozsahin, M" uniqKey="Ozsahin M" first="M." last="Ozsahin">M. Ozsahin</name><name sortKey="Pinotti, G" sort="Pinotti, G" uniqKey="Pinotti G" first="G." last="Pinotti">G. Pinotti</name><name sortKey="Provencio, M" sort="Provencio, M" uniqKey="Provencio M" first="M." last="Provencio">M. Provencio</name><name sortKey="Roy, P" sort="Roy, P" uniqKey="Roy P" first="P." last="Roy">P. Roy</name><name sortKey="Sarris, A H" sort="Sarris, A H" uniqKey="Sarris A" first="A. H." last="Sarris">A. H. Sarris</name><name sortKey="Seymour, J F" sort="Seymour, J F" uniqKey="Seymour J" first="J. F." last="Seymour">J. F. Seymour</name><name sortKey="Thieblemont, C" sort="Thieblemont, C" uniqKey="Thieblemont C" first="C." last="Thieblemont">C. Thieblemont</name><name sortKey="Vitolo, U" sort="Vitolo, U" uniqKey="Vitolo U" first="U." last="Vitolo">U. Vitolo</name></noCountry><country name="Australie"><noRegion><name sortKey="Zucca, E" sort="Zucca, E" uniqKey="Zucca E" first="E." last="Zucca">E. Zucca</name></noRegion></country><country name="Canada"><noRegion><name sortKey="Zucca, E" sort="Zucca, E" uniqKey="Zucca E" first="E." last="Zucca">E. Zucca</name></noRegion><name sortKey="Zucca, E" sort="Zucca, E" uniqKey="Zucca E" first="E." last="Zucca">E. Zucca</name></country><country name="France"><region name="Auvergne-Rhône-Alpes"><name sortKey="Zucca, E" sort="Zucca, E" uniqKey="Zucca E" first="E." last="Zucca">E. Zucca</name></region></country><country name="Italie"><noRegion><name sortKey="Zucca, E" sort="Zucca, E" uniqKey="Zucca E" first="E." last="Zucca">E. Zucca</name></noRegion><name sortKey="Zucca, E" sort="Zucca, E" uniqKey="Zucca E" first="E." last="Zucca">E. Zucca</name><name sortKey="Zucca, E" sort="Zucca, E" uniqKey="Zucca E" first="E." last="Zucca">E. Zucca</name><name sortKey="Zucca, E" sort="Zucca, E" uniqKey="Zucca E" first="E." last="Zucca">E. Zucca</name><name sortKey="Zucca, E" sort="Zucca, E" uniqKey="Zucca E" first="E." last="Zucca">E. Zucca</name><name sortKey="Zucca, E" sort="Zucca, E" uniqKey="Zucca E" first="E." last="Zucca">E. Zucca</name><name sortKey="Zucca, E" sort="Zucca, E" uniqKey="Zucca E" first="E." last="Zucca">E. Zucca</name><name sortKey="Zucca, E" sort="Zucca, E" uniqKey="Zucca E" first="E." last="Zucca">E. Zucca</name><name sortKey="Zucca, E" sort="Zucca, E" uniqKey="Zucca E" first="E." last="Zucca">E. Zucca</name><name sortKey="Zucca, E" sort="Zucca, E" uniqKey="Zucca E" first="E." last="Zucca">E. Zucca</name></country><country name="Pérou"><noRegion><name sortKey="Zucca, E" sort="Zucca, E" uniqKey="Zucca E" first="E." last="Zucca">E. Zucca</name></noRegion></country><country name="Roumanie"><noRegion><name sortKey="Zucca, E" sort="Zucca, E" uniqKey="Zucca E" first="E." last="Zucca">E. Zucca</name></noRegion></country><country name="Espagne"><region name="Communauté de Madrid"><name sortKey="Zucca, E" sort="Zucca, E" uniqKey="Zucca E" first="E." last="Zucca">E. Zucca</name></region></country><country name="Suisse"><noRegion><name sortKey="Zucca, E" sort="Zucca, E" uniqKey="Zucca E" first="E." last="Zucca">E. Zucca</name></noRegion><name sortKey="Zucca, E" sort="Zucca, E" uniqKey="Zucca E" first="E." last="Zucca">E. Zucca</name></country><country name="États-Unis"><noRegion><name sortKey="Zucca, E" sort="Zucca, E" uniqKey="Zucca E" first="E." last="Zucca">E. Zucca</name></noRegion><name sortKey="Zucca, E" sort="Zucca, E" uniqKey="Zucca E" first="E." last="Zucca">E. Zucca</name></country><country name="Royaume-Uni"><noRegion><name sortKey="Zucca, E" sort="Zucca, E" uniqKey="Zucca E" first="E." last="Zucca">E. Zucca</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00B093 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00B093 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= Pascal:03-0109536
|texte= Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the international extranodal lymphoma study group
}}
| This area was generated with Dilib version V0.6.33. |  |